Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
2.1. Market Snapshot: Global Non-Hormonal Alternatives for Menopause Market
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Non-Hormonal Alternatives for Menopause Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Major Industry Challenges
3.2.3. Key Growth Pockets
3.3. Attractive Investment Proposition,2021
3.3.1. Indication
3.3.2. Therapy
3.3.3. End-user
3.3.4. Geography
3.4. Porter’s Five Forces Analysis
3.4.1. Threat of New Entrants
3.4.2. Bargaining Power of Buyers/Consumers
3.4.3. Bargaining Power of Suppliers
3.4.4. Threat of Substitute Indications
3.4.5. Intensity of Competitive Rivalry
3.5. Value Chain Analysis
4. Market Positioning of Key Players, 2021
4.1. Company market share of key players, 2021
4.2. Top 6 Players
4.3. Top 3 Players
4.4. Major Strategies Adopted by Key Players
5. COVID 19 Impact Analysis
5.1. Global Non-Hormonal Alternatives for Menopause Market Pre Vs Post COVID 19, 2019 – 2028
5.2. Impact on Import & Export
5.3. Impact on Demand & Supply
6. North America
6.1. North America Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028(US$ Bn)
6.1.1. U.S.
6.1.2. Canada
6.1.3. Mexico
6.2. North America Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028(US$ Bn)
6.2.1. Overview
6.2.2. Health Women
6.2.3. Breast cancer survivors
6.3. North America Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028(US$ Bn)
6.3.1. Overview
6.3.2. Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
6.3.3. Plant-derived estrogens (phytoestrogens) s
6.3.4. Selective serotonin reuptake inhibitors (SSRIs)
6.3.5. Herbal treatments
6.3.6. Over-the-counter therapies
6.3.7. Others
6.4. North America Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028(US$ Bn)
6.4.1. Overview
6.4.2. Hot Flashes
6.4.3. Vaginal Dryness
6.4.4. Others
7. Europe
7.1. Europe Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028(US$ Bn)
7.1.1. UK
7.1.2. France
7.1.3. Germany
7.1.4. Italy
7.1.5. Russia
7.1.6. Spain
7.1.7. Belgium
7.1.8. Netherland
7.1.9. Austria
7.1.10. Sweden
7.1.11. Poland
7.1.12. Denmark
7.1.13. Switzerland
7.1.14. Rest of Europe
7.2. Europe Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Health Women
7.2.3. Breast cancer survivors
7.3. Europe Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
7.3.3. Plant-derived estrogens (phytoestrogens) s
7.3.4. Selective serotonin reuptake inhibitors (SSRIs)
7.3.5. Herbal treatments
7.3.6. Over-the-counter therapies
7.3.7. Others
7.4. Europe Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028(US$ Bn)
7.4.1. Overview
7.4.2. Hot Flashes
7.4.3. Vaginal Dryness
7.4.4. Others
8. Asia Pacific
8.1. Asia Pacific Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028(US$ Bn)
8.1.1. China
8.1.2. Japan
8.1.3. South Korea
8.1.4. India
8.1.5. Australia
8.1.6. New Zealand
8.1.7. Taiwan
8.1.8. Southeast Asia
8.1.9. Central Asia
8.1.10. Rest of Asia Pacific
8.2. Asia Pacific Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. Health Women
8.2.3. Breast cancer survivors
8.3. Asia Pacific Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
8.3.3. Plant-derived estrogens (phytoestrogens) s
8.3.4. Selective serotonin reuptake inhibitors (SSRIs)
8.3.5. Herbal treatments
8.3.6. Over-the-counter therapies
8.3.7. Others
8.4. Asia Pacific Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028(US$ Bn)
8.4.1. Overview
8.4.2. Hot Flashes
8.4.3. Vaginal Dryness
8.4.4. Others
9. Latin America
9.1. Latin America Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028(US$ Bn)
9.1.1. Brazil
9.1.2. Argentina
9.1.3. Peru
9.1.4. Chile
9.1.5. Colombia
9.1.6. Rest of Latin America
9.2. Latin America Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.1.1. Health Women
9.2.1.2. Breast cancer survivors
9.3. Latin America Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
9.3.3. Plant-derived estrogens (phytoestrogens) s
9.3.4. Selective serotonin reuptake inhibitors (SSRIs)
9.3.5. Herbal treatments
9.3.6. Over-the-counter therapies
9.3.7. Others
9.4. Latin America Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028(US$ Bn)
9.4.1. Overview
9.4.2. Hot Flashes
9.4.3. Vaginal Dryness
9.4.4. Others
10. Middle East
10.1. Middle East Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028(US$ Bn)
10.1.1. UAE
10.1.2. KSA
10.1.3. Israel
10.1.4. Turkey
10.1.5. Iran
10.1.6. Rest of Middle East
10.2. Middle East Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. Health Women
10.2.3. Breast cancer survivors
10.3. Middle East Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
10.3.3. Plant-derived estrogens (phytoestrogens) s
10.3.4. Selective serotonin reuptake inhibitors (SSRIs)
10.3.5. Herbal treatments
10.3.6. Over-the-counter therapies
10.3.7. Others
10.4. Middle East Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028(US$ Bn)
10.4.1. Overview
10.4.2. Hot Flashes
10.4.3. Vaginal Dryness
10.4.4. Others
11. Africa
11.1. Africa Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028(US$ Bn)
11.1.1. South Africa
11.1.2. Egypt
11.1.3. Nigeria
11.1.4. Rest of Africa
11.2. Africa Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. Health Women
11.2.3. Breast cancer survivors
11.3. Africa Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
11.3.3. Plant-derived estrogens (phytoestrogens) s
11.3.4. Selective serotonin reuptake inhibitors (SSRIs)
11.3.5. Herbal treatments
11.3.6. Over-the-counter therapies
11.3.7. Others
11.4. Africa Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028(US$ Bn)
11.4.1. Overview
11.4.2. Hot Flashes
11.4.3. Vaginal Dryness
11.4.4. Others
12. Global
12.1. Global Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. Health Women
12.1.3. Breast cancer survivors
12.2. Global Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
12.2.3. Plant-derived estrogens (phytoestrogens) s
12.2.4. Selective serotonin reuptake inhibitors (SSRIs)
12.2.5. Herbal treatments
12.2.6. Over-the-counter therapies
12.2.7. Others
12.3. Global Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. Hot Flashes
12.3.3. Vaginal Dryness
12.3.4. Others
13. Company Profiles
13.1. Swor Women’s Care
13.2. Paladin Labs
13.3. Boehringer Ingelheim
13.4. Pfizer
13.5. Organon Inc.,
13.6. Lupin
13.7. GSK
13.8. Others
List of Figures
FIG. 1 Global Non-Hormonal Alternatives for Menopause Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Non-Hormonal Alternatives for Menopause Market Segmentation
FIG. 4 Global Non-Hormonal Alternatives for Menopause Market, by Indication, 2019 (US$ Bn)
FIG. 5 Global Non-Hormonal Alternatives for Menopause Market, by Hardware, 2021 (US$ Bn)
FIG. 6 Global Non-Hormonal Alternatives for Menopause Market, by End-user, 2021 (US$ Bn)
FIG. 7 Global Non-Hormonal Alternatives for Menopause Market, by Therapy, 2021 (US$ Bn)
FIG. 8 Global Non-Hormonal Alternatives for Menopause Market, by Geography, 2021 (US$ Bn)
FIG. 9 Attractive InvestHealth Woment Proposition, by Geography, 2021
FIG. 10 Global Market Positioning of Key Non-Hormonal Alternatives for Menopause Market Manufacturers, 2019
FIG. 11 Global Non-Hormonal Alternatives for Menopause Market Value Contribution, By Indication, 2021 & 2028 (Value %)
FIG. 12 Global Non-Hormonal Alternatives for Menopause Market, by Health Women, Value, 2016-2028 (US$ Bn)
FIG. 13 Global Non-Hormonal Alternatives for Menopause Market, by Breast cancer survivors, Value, 2016-2028 (US$ Bn)
FIG. 14 Global Non-Hormonal Alternatives for Menopause Market Value Contribution, By Therapy, 2021 & 2028 (Value %)
FIG. 15 Global Non-Hormonal Alternatives for Menopause Market, by Selective serotonin-norepinephrine reuptake inhibitors (SNRIs), Value, 2016-2028 (US$ Bn)
FIG. 16 Global Non-Hormonal Alternatives for Menopause Market, by Plant-derived estrogens (phytoestrogens), Value, 2016-2028 (US$ Bn)
FIG. 17 Global Non-Hormonal Alternatives for Menopause Market, by Selective serotonin reuptake inhibitors (SSRIs), Value, 2016-2028 (US$ Bn)
FIG. 18 Global Non-Hormonal Alternatives for Menopause Market, by Herbal treatments, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Non-Hormonal Alternatives for Menopause Market, by Over-the-counter therapies, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Non-Hormonal Alternatives for Menopause Market Value Contribution, By End-user, 2021 & 2028 (Value %)
FIG. 21 Global Non-Hormonal Alternatives for Menopause Market, by Hot Flashes, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Non-Hormonal Alternatives for Menopause Market, by Vaginal Dryness, Value, 2016-2028 (US$ Bn)
FIG. 23 U.S. Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 24 Rest of North America Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 25 U.K. Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 26 Germany Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 27 France Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 28 Italy Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 29 Spain Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 30 Russia Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 31 BENELUX Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 32 Poland Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 33 Austria Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 34 Rest of Europe Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 35 Japan Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 36 China Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 37 India Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 38 South Korea Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 39 Australia Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 40 Southeast Asia Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 41 Rest of Asia Pacific Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 42 Middle East & Africa Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 43 South Africa Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 44 Nigeria Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 45 Egypt Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 46 GCC Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 47 Israel Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 48 Latin America Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 49 Mechanicalzil Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 50 Argentina Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 51 Colombia Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 52 Peru Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
FIG. 53 Chile Non-Hormonal Alternatives for Menopause Market, 2016-2028 (US$ Bn)
List of Tables
TABLE 1 Market Snapshot: Global Beauty Devices (Non-Hormonal Alternatives for Menopause) Market
TABLE 2 Global Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028 (US$ Bn)
TABLE 3 Global Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028 (US$ Bn)
TABLE 4 Global Non-Hormonal Alternatives for Menopause Market, by Geography, 2016-2028 (US$ Bn)
TABLE 5 North America Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028 (US$ Bn)
TABLE 6 North America Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028 (US$ Bn)
TABLE 7 North America Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028 (US$ Bn)
TABLE 8 North America Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028 (US$ Bn)
TABLE 9 Europe Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028 (US$ Bn)
TABLE 10 Europe Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028 (US$ Bn)
TABLE 11 Europe Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028 (US$ Bn)
TABLE 12 Europe Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028 (US$ Bn)
TABLE 13 Asia Pacific Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028 (US$ Bn)
TABLE 14 Asia Pacific Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028 (US$ Bn)
TABLE 15 Asia Pacific Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028 (US$ Bn)
TABLE 16 Asia Pacific Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028 (US$ Bn)
TABLE 17 Latin America Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028 (US$ Bn)
TABLE 18 Latin America Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028 (US$ Bn)
TABLE 19 Latin America Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028 (US$ Bn)
TABLE 20 Latin America Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028 (US$ Bn)
TABLE 21 Middle East Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028 (US$ Bn)
TABLE 22 Middle East Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028 (US$ Bn)
TABLE 23 Middle East Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028 (US$ Bn)
TABLE 24 Middle East Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028 (US$ Bn)
TABLE 25 Africa Non-Hormonal Alternatives for Menopause Market, by Country, 2016-2028 (US$ Bn)
TABLE 26 Africa Non-Hormonal Alternatives for Menopause Market, by Indication, 2016-2028 (US$ Bn)
TABLE 27 Africa Non-Hormonal Alternatives for Menopause Market, by End-user, 2016-2028 (US$ Bn)
TABLE 28 Africa Non-Hormonal Alternatives for Menopause Market, by Therapy, 2016-2028 (US$ Bn)